Within a new research, we claimed the identification as well as the characterization of a completely new atypical opioid receptor with exclusive damaging regulatory Attributes in the direction of opioid peptides.1 Our outcomes confirmed that ACKR3/CXCR7, hitherto often known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, can be